Skip to main content

Closed

HCWB: HCW Biologics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-97.9% / yr

Operating margin-97.9%

ROIC-38.4%

Financially safe

Stretched

Debt / equity1.14×

Interest coverage-13.2×

Current ratio0.09×

HCW Biologics Inc.

HCWBNASDAQ Global Market·USD·Closed

HCW Biologics Inc.

HCWBNASDAQ·USD·Closed

$3.20

+1.59%

$3.20

+$0.05 (1.59%)

52W Range

4thpctl

Volume

0.03×avg

Mkt Cap

1.11MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.03×avg

Market Cap

1.11MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings